Literature DB >> 3727974

Human optokinetic afternystagmus. Charging characteristics and stimulus exposure time dependence in the two-component model.

S Lafortune, D J Ireland, R M Jell, L Duval.   

Abstract

The dependence of human optokinetic afternystagmus (OKAN) velocity storage (charging) and optokinetic nystagmus (OKN) characteristics on optokinetic (OK) stimulus exposure time was investigated, using the two-component double exponential model for OKAN decay. Results are compatible with our previously proposed concept of two velocity storage integrators, one responsible for the short time constant decay (pursuit-mediated) and the other for the long time constant decay (OK system-mediated). The dependence of the long time constant integrator of OKAN on stimulus exposure time was clearly demonstrated. The short time constant integrator appeared to be independent of stimulus exposure time within the range studied. We conclude that the charging time-course of each component is distinct from that of the other. The time constants of each component decay were found to be invariant. A left-right asymmetry observed in both OKN and OKAN responses suggests that the integrators are direction sensitive.

Entities:  

Mesh:

Year:  1986        PMID: 3727974     DOI: 10.3109/00016488609108619

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Extraretinal information about eye position during involuntary eye movement: optokinetic afternystagmus.

Authors:  H E Bedell; J F Klopfenstein; N Y Yuan
Journal:  Percept Psychophys       Date:  1989-12

2.  Orientation of human optokinetic nystagmus to gravity: a model-based approach.

Authors:  M Gizzi; T Raphan; S Rudolph; B Cohen
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

3.  Measuring optokinetic after-nystagmus: potential for detecting patients with signs of visual dependence following concussion.

Authors:  Giovanni Bertolini; Fausto Romano; Dominik Straumann; Katharine Keller; Antonella Palla; Nina Feddermann-Demont
Journal:  J Neurol       Date:  2020-12-26       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.